RedHill's CEO On Biopharma's 'Two Shots On Goal' For Coronavirus Drug
REDHILL BIOPHAR/S ADR (NASDAQ: RDHL), known primarily as a biopharmaceutical company focused on gastrointestinal diseases, is joining the race to develop coronavirus treatments with two pipeline drugs it believes can help treat the disease that's triggered a pandemic.
